Skip to main content
. 2004 Jul;186(13):4295–4306. doi: 10.1128/JB.186.13.4295-4306.2004

TABLE 2.

p distances within disease groups determined based on the number of nucleotide and amino acid differences

Disease group and compound type No. (SE; % change) of nucleotide or amino acid changes
pmpC pmpE pmpH pmpI
Ocular
    Nucleotide 4.5 (1.5; <0.1) 4.3 (1.5; 0.2) 2.0 (0.9; <0.1) 5.7 (1.9; 0.2)
    Amino acid 3.0 (1.2; 0.2) 2.7 (1.1; 0.3) 0.5 (0.5; <0.1) 1.0 (0.7; 0.1)
Urogenital
    Nucleotide 20.7 (3.2; 0.4) 33.2 (4.1; 1.2) 6.7 (1.6; 0.2) 8.3 (1.9; 0.3)
    Amino acid 15 (2.7; 0.8) 9.9 (2.0; 1.1) 2.1 (0.9; 0.2) 4.1 (1.2; 0.5)
LGV
    Nucleotide 5.3 (1.6; 0.1) 6.0 (1.9; 0.2) 2.7 (1.3; <0.1) 0.7 (0.7; <0.1)
    Amino acid 4.2 (1.5; 0.2) 2.0 (1.1; 0.2) 1.3 (0.9; 0.1) 0 (0; 0)